The dynamic regulation of endothelial pathophenotypes in pulmonary hypertension (PH) remains undefined. Cellular senescence is linked to PH with intracardiac shunts; however, its regulation across PH subtypes is unknown. Since endothelial deficiency of iron-sulfur (Fe-S) clusters is pathogenic in PH, we hypothesized that a Fe-S biogenesis protein, frataxin (FXN), controls endothelial senescence. An endothelial subpopulation in rodent and patient lungs across PH subtypes exhibited reduced FXN and elevated senescence. In vitro, hypoxic and inflammatory FXN deficiency abrogated activity of endothelial Fe-S–containing polymerases, promoting replication stress, DNA damage response, and senescence. This was also observed in stem cell–derived endothelial cells from Friedreich’s ataxia (FRDA), a genetic disease of FXN deficiency, ataxia, and cardiomyopathy, often with PH. In vivo, FXN deficiency–dependent senescence drove vessel inflammation, remodeling, and PH, whereas pharmacologic removal of senescent cells in Fxn-deficient rodents ameliorated PH. These data offer a model of endothelial biology in PH, where FXN deficiency generates a senescent endothelial subpopulation, promoting vascular inflammatory and proliferative signals in other cells to drive disease. These findings also establish an endothelial etiology for PH in FRDA and left heart disease and support therapeutic development of senolytic drugs, reversing effects of Fe-S deficiency across PH subtypes.
Miranda K. Culley, Jingsi Zhao, Yi Yin Tai, Ying Tang, Dror Perk, Vinny Negi, Qiujun Yu, Chen-Shan C. Woodcock, Adam Handen, Gil Speyer, Seungchan Kim, Yen-Chun Lai, Taijyu Satoh, Annie M.M. Watson, Yassmin Al Aaraj, John Sembrat, Mauricio Rojas, Dmitry Goncharov, Elena A. Goncharova, Omar F. Khan, Daniel G. Anderson, James E. Dahlman, Aditi U. Gurkar, Robert Lafyatis, Ahmed U. Fayyaz, Margaret M. Redfield, Mark T. Gladwin, Marlene Rabinovitch, Mingxia Gu, Thomas Bertero, Stephen Y. Chan
Title and authors | Publication | Year |
---|---|---|
Lysosomal dysfunction and inflammatory sterol metabolism in pulmonary arterial hypertension
Harvey LD, Alotaibi M, Tai YY, Tang Y, Kim HJ, Kelly NJ, Sun W, Woodcock CS, Arshad S, Culley MK, El Khoury W, Xie R, Al Aaraj Y, Zhao J, Hafeez N, Rao RJ, Jiang S, Negi V, Kirillova A, Perk D, Watson AM, St. Croix CM, Stolz DB, Lee JY, Cheng MH, Zhang M, Detmer S, Guzman E, Manan RS, Saggar R, Haley KJ, Waxman AB, Okawa S, Schwantes-An TH, Pauciulo MW, Wang B, Webb A, Chauvet C, Anderson DG, Nichols WC, Desai AA, Lafyatis R, Nouraie SM, Wu H, McDonald JG, Cheng S, Bahar I, Bertero T, Benza RL, Jain M, Chan SY |
Science (New York, N.Y.) | 2025 |
RAB7 deficiency impairs pulmonary artery endothelial function and promotes pulmonary hypertension
Bryce Piper, Srimathi Bogamuwa, Tanvir Hossain, Daniela Farkas, Lorena Rosas, Adam Green, Geoffrey Newcomb, Nuo Sun, Jeffrey Horowitz, Aneel Bhagwani, Hu Yang, Tatiana Kudryashova, Mauricio Rojas, Ana Mora, Pearlly Yan, Rama Mallampalli, Elena Goncharova, David Eckmann, Laszlo Farkas |
Journal of Clinical Investigation | 2024 |
Allele-specific control of rodent and human lncRNA KMT2E-AS1 promotes hypoxic endothelial pathology in pulmonary hypertension
Tai YY, Yu Q, Tang Y, Sun W, Kelly NJ, Okawa S, Zhao J, Schwantes-An TH, Lacoux C, Torrino S, Aaraj YA, Khoury WE, Negi V, Liu M, Corey CG, Belmonte F, Vargas SO, Schwartz B, Bhat B, Chau BN, Karnes JH, Satoh T, Barndt RJ, Wu H, Parikh VN, Wang J, Zhang Y, McNamara D, Li G, Speyer G, Wang B, Shiva S, Kaufman B, Kim S, Gomez D, Mari B, Cho MH, Boueiz A, Pauciulo MW, Southgate L, Trembath RC, Sitbon O, Humbert M, Graf S, Morrell NW, Rhodes CJ, Wilkins MR, Nouraie M, Nichols WC, Desai AA, Bertero T, Chan SY |
Science Translational Medicine | 2024 |
Endothelium-specific SIRT7 targeting ameliorates pulmonary hypertension through Krüpple-like factor 4 deacetylation
Zhang J, Xu C, Tang X, Sun S, Liu S, Yang L, Chen Y, Yang Q, Wei TY, Wu X, Wang J, Wang C, Yan X, Yang L, Niu Y, Gou D, Shyy JY, Liu B |
Cardiovascular Research | 2024 |
Mediating Metabolism: Inhibition of Malic Enzyme 1 (ME1) Restores Endothelial Bioenergetics and Adenosine Signaling in Pulmonary Hypertension.
Rao RJ, Chan SY |
Circulation | 2024 |
miR-21-Mediated Endothelial Senescence and Dysfunction Are Involved in Cigarette Smoke-Induced Pulmonary Hypertension through Activation of PI3K/AKT/mTOR Signaling
He B, Shao B, Cheng C, Ye Z, Yang Y, Fan B, Xia H, Wu H, Liu Q, Zhang J |
Toxics | 2024 |
Cell Death in Pulmonary Arterial Hypertension
Li X, Tan J, Wan J, Cheng B, Wang YH, Dai A |
International journal of medical sciences | 2024 |
Cellular senescence in the pathogenesis of pulmonary arterial hypertension: the good, the bad and the uncertain
Safaie Qamsari E, Stewart DJ |
Frontiers in Immunology | 2024 |
Identification and experimental verification of senescence-related gene signatures and molecular subtypes in idiopathic pulmonary arterial hypertension
Meng ZY, Lu CH, Li J, Liao J, Wen H, Li Y, Huang F, Zeng ZY |
Scientific Reports | 2024 |
New Horizons in Myotonic Dystrophy Type 1: Cellular Senescence as a Therapeutic Target
Légaré C, Berglund JA, Duchesne E, Dumont NA |
Bioessays | 2024 |
Frataxin Loss Promotes Angiotensin II–Induced Endothelial‐to‐Mesenchymal Transition
Guo Y, Cheng X, Huang C, Gao J, Shen W |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2024 |
PGC-1α-mediated angiogenesis prevents pulmonary hypertension in mice
Takayuki Fujiwara, Norifumi Takeda, Hironori Hara, Satoshi Ishii, Genri Numata, Hiroyuki Tokiwa, Manami Katoh, Sonoko Maemura, Takaaki Suzuki, Hiroshi Takiguchi, Tomonobu Yanase, Yoshiaki Kubota, Seitaro Nomura, Masaru Hatano, Kazutaka Ueda, Mutsuo Harada, Haruhiro Toko, Eiki Takimoto, Hiroshi Akazawa, Hiroyuki Morita, Satoshi Nishimura, Issei Komuro |
JCI Insight | 2023 |
Single Nucleotide Polymorphism rs9277336 Controls the Nuclear Alpha Actinin 4‐Human Leukocyte Antigen‐DPA1 Axis and Pulmonary Endothelial Pathophenotypes in Pulmonary Arterial Hypertension
Hafeez N, Kirillova A, Yue Y, Rao RJ, Kelly NJ, El Khoury W, Al Aaraj Y, Tai Y, Handen A, Tang Y, Jiang D, Wu T, Zhang Y, McNamara D, Kudryashova TV, Goncharova EA, Goncharov D, Bertero T, Nouraie M, Li G, Sun W, Chan SY |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2023 |
Senescent Cells: A Therapeutic Target in Cardiovascular Diseases.
Suda M, Paul KH, Minamino T, Miller JD, Lerman A, Ellison-Hughes GM, Tchkonia T, Kirkland JL |
Cells | 2023 |
Endothelial cell senescence exacerbates pulmonary hypertension by inducing juxtacrine Notch signaling in smooth muscle cells
Ramadhiani R, Ikeda K, Miyagawa K, Ryanto GR, Tamada N, Suzuki Y, Kirita Y, Matoba S, Hirata KI, Emoto N |
iScience | 2023 |
Targeting Mitochondrial Metabolic Dysfunction in Pulmonary Hypertension: Toward New Therapeutic Approaches?
Riou M, Enache I, Sauer F, Charles AL, Geny B |
International journal of molecular sciences | 2023 |
TGFβ signaling pathways in human health and disease
Chen PY, Qin L, Simons M |
Frontiers in Molecular Biosciences | 2023 |
Vascular Inflammatory Diseases and Endothelial Phenotypes
Immanuel J, Yun S |
Cells | 2023 |
SIRT3 Regulates Clearance of Apoptotic Cardiomyocytes by Deacetylating Frataxin
Gao J, Huang C, Kong L, Zhou W, Sun M, Wei T, Shen W |
Circulation research | 2023 |
Frataxin deficiency disrupts mitochondrial respiration and pulmonary endothelial cell function
Culley MK, Rao RJ, Mehta M, Zhao J, Khoury WE, Harvey LD, Perk D, Tai YY, Tang Y, Shiva S, Rabinovitch M, Gu M, Bertero T, Chan SY |
Vascular Pharmacology | 2023 |
The mechanism of ferroptosis and its related diseases
Feng S, Tang D, Wang Y, Li X, Bao H, Tang C, Dong X, Li X, Yang Q, Yan Y, Yin Z, Shang T, Zheng K, Huang X, Wei Z, Wang K, Qi S |
2023 | |
Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFκB inactivation
Ratoe Suraya, Tatsuya Nagano, Gusty R.T. Ryanto, Wiwin I. Effendi, Daisuke Hazama, Naoko Katsurada, Masatsugu Yamamoto, Motoko Tachihara, Noriaki Emoto, Yoshihiro Nishimura, Kazuyuki Kobayashi |
Respiratory Research | 2022 |
The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure
O Boucherat, V Agrawal, A Lawrie, S Bonnet |
Circulation research | 2022 |
Endothelial Senescence: A New Age in Pulmonary Hypertension
M Culley, S Chan |
Circulation research | 2022 |
Mechanisms of pulmonary vascular dysfunction in pulmonary hypertension and implications for novel therapies
H Christou, R Khalil |
American journal of physiology. Heart and circulatory physiology | 2022 |
Loss of Amphiregulin drives inflammation and endothelial apoptosis in pulmonary hypertension.
Florentin J, Zhao J, Tai YY, Sun W, Ohayon LL, O'Neil SP, Arunkumar A, Zhang X, Zhu J, Al Aaraj Y, Watson A, Sembrat J, Rojas M, Chan SY, Dutta P |
Life science alliance | 2022 |
Perspectives on current models of Friedreich’s ataxia
Kelekçi S, Yıldız AB, Sevinç K, Çimen DU, Önder T |
Frontiers in Cell and Developmental Biology | 2022 |
Mechanisms and consequences of endothelial cell senescence.
Bloom SI, Islam MT, Lesniewski LA, Donato AJ |
Nature reviews. Cardiology | 2022 |
Endothelial senescence mediates hypoxia-induced vascular remodeling by modulating PDGFB expression
Kyi P, Hendee K, Hunyenyiwa T, Matus K, Mammoto T, Mammoto A |
Frontiers in Medicine | 2022 |
Pulmonary Arterial Hypertension: Emerging Principles of Precision Medicine across Basic Science to Clinical Practice
Kelly NJ, Chan SY |
2022 | |
How a fibroblast ages: a role for bone morphogenetic protein 4 in protecting lung fibroblasts from senescence in pulmonary fibrosis.
Farkas L, Horowitz JC, Mora AL |
European Respiratory Journal | 2022 |
Therapeutic opportunities for senolysis in cardiovascular disease
Sweeney M, Cook SA, Gil J |
The FEBS journal | 2022 |
Frataxin and endothelial cell senescence in pulmonary hypertension
Allan Lawrie |
Journal of Clinical Investigation | 2021 |
Senescence Alterations in Pulmonary Hypertension
I Roger, J Milara, N Belhadj, J Cortijo |
Cells | 2021 |